Conti A A
Clinica Medica Generale e Cardiologia, Fondazione Don Carlo Gnocchi, Centro S. Maria agli Ulivi, IRCCS, Università degli Studi di Firenze, Pozzolatico, Firenze, Italy.
Minerva Med. 2002 Oct;93(5):347-55.
Diabetic nephropathy is the major chronic complication of diabetes mellitus for mortality and morbidity. It is a condition of renal damage appearing in the course of diabetes mellitus, with a clinical expression characterized by urinary signs and arterial hypertension. This condition is functionally distinguished by a progressive decrease of the glomerular filtration rate, and in the Western world it is currently the major determinant of end stage renal disease. In the last twenty years the incidence of renal failure in the course of diabetes mellitus has grown continuously, particularly in type 2 diabetic patients. The majority of patients with diabetic nephropathy reach end-stage renal failure within ten years from the first evidence of proteinuria, and, in the United States, about 30% of the chronically dyalitic patients have diabetic nephropathy. The identification and the control of the renal disease over time are based on the measurement of proteinuria. Although the most useful and reliable dosage methods for proteinuria are still debated, it appears clear today that a spot measurement of albuminuria is not a reliable indication for the diagnosis of diabetic renal disease. The measurement of albuminuria as well as of creatinuria several times a year in the diabetic subject is therefore recommended, considering also that the test needs repetition both when positive and negative. Despite of the relevant results achieved in the last few years by clinical research both in the diagnostic and in the therapeutic fields, the role of prophylactic measures still remains essential in diabetics at higher risk of nephropathy.
糖尿病肾病是糖尿病导致死亡和发病的主要慢性并发症。它是糖尿病病程中出现的一种肾脏损害疾病,临床表现以泌尿系统症状和动脉高血压为特征。这种疾病在功能上的特点是肾小球滤过率逐渐下降,在西方世界,它目前是终末期肾病的主要决定因素。在过去二十年中,糖尿病病程中肾衰竭的发病率持续上升,尤其是在2型糖尿病患者中。大多数糖尿病肾病患者在出现蛋白尿的最初迹象后的十年内会发展为终末期肾衰竭,在美国,约30%的长期透析患者患有糖尿病肾病。随着时间的推移,对肾脏疾病的识别和控制基于蛋白尿的测量。尽管对于蛋白尿最有用和可靠的检测方法仍存在争议,但如今很明显,单次尿白蛋白检测并不是诊断糖尿病肾病的可靠指标。因此,建议糖尿病患者每年多次检测尿白蛋白和尿肌酐,同时考虑到检测结果无论是阳性还是阴性都需要重复检测。尽管近年来临床研究在诊断和治疗领域都取得了显著成果,但对于肾病高危糖尿病患者,预防措施的作用仍然至关重要。